Renal Damages in Deoxycorticosterone Acetate-Salt Hypertensive Rats: Assessment with Diffusion Tensor Imaging and T2-mapping

被引:6
|
作者
Ko, Sheung-Fat [1 ]
Yip, Hon-Kan [2 ,3 ]
Zhen, Yen-Yi [4 ]
Hung, Chi-Chih [4 ]
Lee, Chen-Chang [1 ]
Huang, Chung-Cheng [1 ]
Ng, Shu-Hang [1 ]
Chen, Yi-Ling [1 ,3 ]
Lin, Jui-Wei [5 ]
机构
[1] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Coll Med, 123 Ta Pei Rd, Kaohsiung 833, Taiwan
[2] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Kaohsiung, Taiwan
[3] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Coll Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan
[5] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Coll Med, Kaohsiung, Taiwan
关键词
Hypertension; Hypertensive kidney injury; Diffusion tensor imaging; Fractional anisotropy; Mean diffusivity; T2-mapping; Rats; ACUTE KIDNEY INJURY; BLOOD-PRESSURE; FIBROSIS; MRI; COEFFICIENT; HYPOXIA; DISEASE;
D O I
10.1007/s11307-019-01364-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose This study aimed to investigate the feasibility of diffusion tensor imaging (DTI) and T2-mapping to assess temporal renal damage in deoxycorticosterone acetate-salt (DOCA-salt) hypertensive rats and compare the results with histopathologic and immunohistochemical findings. Procedures After baseline renal magnetic resonance imaging (MRI), 24 out of 30 uninephrectomized Sprague-Dawley rats with DOCA-salt-induced hypertension were divided equally into four groups. Group 1 had renal MRI at weeks 2, 4, 6, and 8, and groups 2, 3, and 4 had MRI at weeks 2, 4, and 6, respectively. The remaining 6 rats were used as sham controls. The renal cortex and outer and inner stripes of the outer medulla were examined over time using fractional anisotropy (FA), apparent diffusion coefficient (ADC), and T2-mapping, and the results were compared with baseline values. The degree of glomerular and tubular injury, endothelial cell thickening, hyaline arteriolosclerosis, macrophage infiltration, microcyst formation, and fibrosis in different zones at different time points in the DOCA-salt rats were compared with controls. Results Compared with baseline values, DOCA-salt rats demonstrated a significant decrease in renal cortical FA from week 4 to week 8 (0.244 +/- 0.015 vs 0.172 +/- 0.014-0.150 +/- 0.016, P = 0.018-0.002), corresponding to significantly more glomerular damage, arteriolosclerosis, macrophage infiltration, and fibrosis. The DOCA-salt rats had significantly increased cortical ADC and T2 values at weeks 6 and 8 (1.778 +/- 0.051 x 10(-3) mm(2)/s vs 1.872 +/- 0.058-1.917 +/- 0.066 x 10(-3) mm(2)/s; 93.7 +/- 4.9 ms vs 98.0 +/- 2.9-100.7 +/- 4.0 ms, respectively, all P < 0.05), consistent with excessively fluid-filled microcysts (aquaporin-2+). Despite DOCA-salt rats harbored markedly increased fibrosis in outer and inner stripes of the outer medulla at weeks 6 and 8, only nonsignificant decreases in FA were observed in comparison with the controls suggesting that only limited microstructural changes were present. Conclusions Renal cortical FA is useful for the early detection and monitoring of renal damage in DOCA-salt hypertensive rats.
引用
收藏
页码:94 / 104
页数:11
相关论文
共 50 条
  • [1] Renal Damages in Deoxycorticosterone Acetate–Salt Hypertensive Rats: Assessment with Diffusion Tensor Imaging and T2-mapping
    Sheung-Fat Ko
    Hon-Kan Yip
    Yen-Yi Zhen
    Chi-Chih Hung
    Chen-Chang Lee
    Chung-Cheng Huang
    Shu-Hang Ng
    Yi-Ling Chen
    Jui-Wei Lin
    Molecular Imaging and Biology, 2020, 22 : 94 - 104
  • [2] Renal impairment in deoxycorticosterone acetate-salt hypertensive rats
    Dallemagne, C
    Ooi, SY
    Brown, L
    Gobé, G
    Endre, Z
    NEPHROLOGY, 2000, 5 (04) : 277 - 284
  • [3] Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats
    Lee, Tsung-Ming
    Chen, Chien-Chang
    Chang, Nen-Chung
    CLINICAL SCIENCE, 2012, 123 (7-8) : 445 - 457
  • [4] Renal protective effect of Melothria maderaspatana leaf fraction on uninephrectomized deoxycorticosterone acetate-salt hypertensive rats
    Veeramani, Chinnadurai
    Al-Numair, Khalid S.
    Chandramohan, Govindasamy
    Alsaif, Mohammed A.
    Pugalendi, Kodukkur Viswanathan
    PROGRESS IN NUTRITION, 2014, 16 (03): : 204 - 211
  • [5] Effect of pravastatin on nephroprotection in deoxycorticosterone acetate-salt hypertensive rats
    Kang, Chih-Sen
    Chang, Nen-Chung
    Chang, Shen-Tien
    Lin, Chih-Chan
    Lee, Tsung-Ming
    JOURNAL OF HYPERTENSION, 2009, 27 (11) : 2232 - 2243
  • [6] Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats
    Safaeian, Leila
    Emami, Reyhaneh
    Hajhashemi, Valiollah
    Haghighatian, Zahra
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 100 : 147 - 155
  • [7] Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats
    Jadhav, Ashok
    Torlakovic, Emina
    Ndisang, Joseph Fomusi
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 296 (03) : F521 - F534
  • [8] A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats
    Takaoka, M
    Ohkita, M
    Itoh, M
    Kobayashi, Y
    Okamoto, H
    Matsumura, Y
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2001, 28 (5-6) : 466 - 468
  • [9] Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats
    Boesen, Erika I.
    Williams, Douglas L.
    Pollock, Jennifer S.
    Pollock, David M.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (10) : 1016 - 1022
  • [10] Antihypertensive and Renoprotective Effects of Dietary Flaxseed and its Mechanism of Action in Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Watanabe, Yusuke
    Ohata, Kaori
    Fukanoki, Ayaka
    Fujimoto, Naoto
    Matsumoto, Maruri
    Nessa, Naseratun
    Toba, Hiroe
    Kobara, Miyuki
    Nakata, Tetsuo
    PHARMACOLOGY, 2020, 105 (1-2) : 54 - 62